Overview

The Confidence to Know Bleeding Will Stop

We developed the Veriset™ hemostatic patch based on six years of scientific research and development. It’s designed to help you achieve hemostasis quickly and consistently.([FOOTNOTE=Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ hemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery [published online Dec. 27, 2012]. HPB (Oxford). 2013;15(7):548-58. doi: 10.1111/hpb.12009.],[ANCHOR=],[LINK=])


*The Veriset™ hemostatic patch is not available for sale in the United States.

Features

Fast and Reliable

  • 75% of patients achieve hemostasis in approximately 1 minute1
  • Hold for only 30 seconds([FOOTNOTE=Based on Veriset™ hemostatic patch instructions for use and product specifications. 2014.],[ANCHOR=],[LINK=])

Increased Patient Safety

  • 100% free of human or animal components, eliminating risk of viral transmission2

Effective

  • Effective in cases of inhibited coagulation, independent of clotting ability shown in a pre-clinical study([FOOTNOTE=Sponsored preclinical study assessing CV and PV models on animals with inhibited platelet activity (heparin, aspirin, Plavix™*). 2010.
    ],[ANCHOR=],[LINK=])
  • Significantly superior performance compared to TachoSil™*1,([FOOTNOTE=Based on internal test study #COVEUCV0140-CSR, Study to compare the Veriset™ hemostatic patch to TachoSil™* as an adjunct to hemostasis in subjects undergoing cardiovascular surgery. March 2014. Data on file.],[ANCHOR=],[LINK=])

Versatile

  • Can be used in both open and laparoscopic procedures2
  • Easily passes through trocar([FOOTNOTE=Based on internal study #TR1478, Evaluating Veriset™ hemostatic patch after laparoscopic liver resection in a porcine model. 2013.],[ANCHOR=],[LINK=])

Order Information

Technology

Increase Patient Safety

Unlike any other high-efficacy hemostat, the Veriset™ patch is 100% free of human components² — eliminating the risk of viral transmission.

    1. Oxidized regnerated cellulose (Layer 1)

  • 3-D pattern allows for blood absorption
  • Known to promote hemostasis via a reduction in blood pH
  • Acts as a tamponade

    2. Trilysine (layer 2)

  • Combines with the PEG to form a hydrogel barrier

    3. Reactive polyethylene glycol (PEG) (Layer 3)

  • Propriety sealant technology
  • Effective barrier to blood flow
  • Adheres the patch to the bleeding site

Universal UseΩ

Effective in cases of inhibited coagulation and independent of clotting ability as shown in a pre-clinical study.³

    1. Placement

  • PEG side (darker) of the Veriset™ patch placed against the bleeding site2
  • Blood whisks into the patch and it becomes compliant

    2. Pressure

  • The oxidized regenerated cellulose within the patch absorbs blood and initiates the coagulation process by a reduction in blood pH

    3. Polymerization

  • Polymer components cross-link to form an impenetrable barrier (hydrogel).2 It then adheres to the bleeding site

    4. Hemostasis

  • Hemostasis is achieved in approximately 1 minute1

    5. Absorption

  • Veriset™ patch is fully absorbed in approximately 4 weeks²

Easy to Use1,2

  • No special storage requirements guarantees easy access when needed²
  • Ready to use in both open and laparoscopic procedures with no preparation time²
Veriset™ Hemostatic Patch Universal Use

Resources

  • Ω Based on serum plasma morphology.